Literature DB >> 2191722

Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor.

J Williams1, B Rucinski, J Holt, S Niewiarowski.   

Abstract

The RGD-containing peptides isolated from the venoms of the Viperidae constitute a new class of small cysteine-rich peptides of variable amino acid composition and biological activity (Huang, T.-F., et al. (1987) J. Biol. Chem. 262, 16157-16163; Gan, Z.R., et al. (1988) J. Biol. Chem 263, 19827-19832; Huang, T.-F., et al. (1989) Biochemistry 28, 661-668), which it is proposed by Gould et al. (unpublished data) that we call 'disintegrins'. These peptides bind to the glycoprotein IIb-IIIa receptor on the platelet surface and inhibit aggregation induced by ADP, thrombin, platelet-activating factor and collagen. These peptides are also potent inhibitors of cell adhesion to fibrinogen (Knudsen, K.M., et al. (1988) Exp. Cell Res. 179, 42-49). We report the isolation of two further RGD-peptides from the venoms of Trimeserusus elegans and Trimeserusus albolabris, purified to homogeneity with high yield by a novel, rapid reverse-phase HPLC method. The primary structures of these two peptides were determined to be single polypeptide chains of 73 amino acids. Albolabrin differed from trigramin by eight residues whilst elegantin differed by 22 residues. The molecular mass of albolabrin calculated on the basis of amino acid sequence was 7574 Da and the pI similarly calculated was 4.27. The molecular mass of elegantin was calculated to be 7806 Da and the theoretical pI to be 4.69. RGD is maintained in the same position (51-53 AA) and all 12 cysteines are identical. Our data suggest that the presence of RGD, the conserved secondary and tertiary structure, are essential for the expression of biological activity by these peptides. Both peptides inhibited ADP-induced platelet aggregation. Extended homologies around the RGDS sequences in human von Willebrand Factor and bovine fibrinogen were found with both peptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191722     DOI: 10.1016/0167-4838(90)90229-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Arg-Tyr-Asp (RYD) and Arg-Cys-Asp (RCD) motifs in dendroaspin promote selective inhibition of beta1 and beta3 integrins.

Authors:  B Wattam; D Shang; S Rahman; S Egglezou; M Scully; V Kakkar; X Lu
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

2.  An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IV.

Authors:  P S Wright; V Saudek; T J Owen; S L Harbeson; A J Bitonti
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

3.  Amino acid sequence and molecular modelling of glycoprotein IIb-IIIa and fibronectin receptor iso-antagonists from Trimeresurus elegans venom.

Authors:  A Scaloni; E Di Martino; N Miraglia; A Pelagalli; R Della Morte; N Staiano; P Pucci
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.

Authors:  S Rahman; X Lu; V V Kakkar; K S Authi
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

5.  Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins.

Authors:  C Marcinkiewicz; L A Rosenthal; D M Mosser; T J Kunicki; S Niewiarowski
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

6.  cDNA cloning of a snake venom metalloproteinase from the eastern diamondback rattlesnake (Crotalus adamanteus), and the expression of its disintegrin domain with anti-platelet effects.

Authors:  Montamas Suntravat; Ying Jia; Sara E Lucena; Elda E Sánchez; John C Pérez
Journal:  Toxicon       Date:  2013-01-10       Impact factor: 3.033

7.  Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets.

Authors:  M A McLane; M A Kowalska; L Silver; S J Shattil; S Niewiarowski
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

8.  Synthetic RGD peptides derived from the adhesive domains of snake-venom proteins: evaluation as inhibitors of platelet aggregation.

Authors:  X Lu; J J Deadman; J A Williams; V V Kakkar; S Rahman
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

9.  Determination of the structure of two novel echistatin variants and comparison of the ability of echistatin variants to inhibit aggregation of platelets from different species.

Authors:  Y L Chen; T F Huang; S W Chen; I H Tsai
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

10.  Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation.

Authors:  S Rahman; A Aitken; G Flynn; C Formstone; G F Savidge
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.